Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Depreciation and Depletion: 2017-2024

Historic Depreciation and Depletion for Kiniksa Pharmaceuticals International (KNSA) over the last 8 years, with Dec 2024 value amounting to $448,000.

  • Kiniksa Pharmaceuticals International's Depreciation and Depletion fell 68.97% to $27,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $163,000, marking a year-over-year decrease of 72.65%. This contributed to the annual value of $448,000 for FY2024, which is 59.60% down from last year.
  • Kiniksa Pharmaceuticals International's Depreciation and Depletion amounted to $448,000 in FY2024, which was down 59.60% from $1.1 million recorded in FY2023.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Depreciation and Depletion ranged from a high of $2.4 million in FY2020 and a low of $448,000 during FY2024.
  • For the 3-year period, Kiniksa Pharmaceuticals International's Depreciation and Depletion averaged around $912,000, with its median value being $1.1 million (2023).
  • Per our database at Business Quant, Kiniksa Pharmaceuticals International's Depreciation and Depletion rose by 16.30% in 2020 and then tumbled by 59.60% in 2024.
  • Kiniksa Pharmaceuticals International's Depreciation and Depletion (Yearly) stood at $2.4 million in 2020, then tumbled by 39.50% to $1.5 million in 2021, then decreased by 18.97% to $1.2 million in 2022, then dropped by 5.94% to $1.1 million in 2023, then crashed by 59.60% to $448,000 in 2024.